A survey of antidepressant drug use in Parkinson's disease

Neurology

Volumn 49, Issue 4, 1997, Pages 1168-1170

  Richard, Irene Hegeman ^a   Kurlan, Roger ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; ISOCARBOXAZID; MAPROTILINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

ARTICLE; DEPRESSION; DRUG CHOICE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; HEALTH SURVEY; HUMAN; MOTOR PERFORMANCE; PARKINSON DISEASE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SIDE EFFECT; SLEEP;

EID: 0030664249     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.4.1168     Document Type: Article

References (7)

1. Dooneief G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol 1992;49:305-307.
2. Mayeux R, Stern Y, Cote L, Williams JBW. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 1984;34:642-646.
3. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996;57:449-454.
4. Caley CF, Friedman JH. Does fluoxetine exacerbate Parkinson's disease? J Clin Psychiatry 1992;53:278-282.
5. Montastruc JL, Fabre N, Blin O, Senard JM, Rascol O, Rascol A. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study. Mov Disord 1995;10:355-357.
6. Hauser RA, Zesiewicz TA. Sertraline for the treatment of depression in Parkinson's disease [abstract]. Mov Disord 1996;11: 12.
7. Klaassen T, Verhey FRJ, Sneijders GHJM, Rozendaal N, de Vet HCW, van Praag HM. Treatment of depression in Parkinson's disease: a meta-analysis. J Neuropsychiatry Clin Neurosci 1995;7:281-286.